Key result
Vasodilating β-blockers were associated with a lower 1-year incidence of cardiac death compared to conventional β-blockers (1.0% vs 1.9%; P=0.003) in patients with acute MI.
Why the study?
Does vasodilating β-blocker therapy reduce cardiac death compared to conventional β-blockers in patients with acute MI after successful PCI?
Population
7127 patients with acute myocardial infarction who underwent successful percutaneous coronary intervention…
Comparison
Vasodilating β-blocker vs Conventional β-blocker
Design
Cohort
Follow-up
1 year
Authors
Loading...
Should not yet change β-blocker selection post-MI; leaves open whether vasodilating agents reduce cardiac death versus conventional agents.
Cohort (n=7,127)
Yes
Does vasodilating β-blocker therapy reduce cardiac death compared to conventional β-blockers in patients with acute MI after successful PCI?
Absolute Event Rate: 1% vs 1.9%
p-value: p=0.003
Vasodilating β-blockers are associated with a lower incidence of cardiac death at 1 year compared to conventional β-blockers in patients with acute MI after successful PCI.
Chung et al. (2017) conducted a cohort in acute myocardial infarction (n=7,127). Vasodilating β-blocker vs. Conventional β-blocker was evaluated on cardiac death at 1 year (p=0.003). Vasodilating β-blockers were associated with a lower 1-year incidence of cardiac death compared to conventional β-blockers (1.0% vs 1.9%; P=0.003) in patients with acute MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: